Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides

Background: Information on genotypic with comparison of phenotypic drug sensitivity test of anti-tuberculosis (TB) has been reported in several studies, which have variable results. The present study aimed to assess the Genotype MTBDRsl version 2.0/Line probe assay (LPA) for the detection of fluoroq...

Full description

Bibliographic Details
Main Authors: Ramalingam Radhakrishnan, S Prabuseenivasan, S Hannah, V Vaishanavee, V Senthildevi, T Kannadhasan, R Suchithra, Priya Rajendran, Ponnuraja Chinnaiyan, Lavanya Jayabal, Asha Frederick, Sivakumar Shanmugam
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:International Journal of Mycobacteriology
Subjects:
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2023;volume=12;issue=3;spage=299;epage=304;aulast=Radhakrishnan
_version_ 1797649325661093888
author Ramalingam Radhakrishnan
S Prabuseenivasan
S Hannah
V Vaishanavee
V Senthildevi
T Kannadhasan
R Suchithra
Priya Rajendran
Ponnuraja Chinnaiyan
Lavanya Jayabal
Asha Frederick
Sivakumar Shanmugam
author_facet Ramalingam Radhakrishnan
S Prabuseenivasan
S Hannah
V Vaishanavee
V Senthildevi
T Kannadhasan
R Suchithra
Priya Rajendran
Ponnuraja Chinnaiyan
Lavanya Jayabal
Asha Frederick
Sivakumar Shanmugam
author_sort Ramalingam Radhakrishnan
collection DOAJ
description Background: Information on genotypic with comparison of phenotypic drug sensitivity test of anti-tuberculosis (TB) has been reported in several studies, which have variable results. The present study aimed to assess the Genotype MTBDRsl version 2.0/Line probe assay (LPA) for the detection of fluoroquinolones (FQ) and aminoglycosides (AMGs) resistance mutations among drug-resistant Mycobacterium TB (MTB) strains and also to compare the patterns of genotypic mutations of gyrA/B, rrs, and eis with mycobacteria growth indicator tube (MGIT 960). Methods: A total of 1416 samples were subjected to Genotype MTBDRsl version 2.0 assay. One hundred and twenty sputum smear positive MTB isolates and 37 sputum smear negative MTB isolates confirmed multiple drug resistance resistant to FQ and AMG by the Genotype MTBDRsl version 2.0 were subjected to phenotypic drug susceptibility testing (DST) were analyzed. Results: The association sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for the resistance detection between MGIT (DST) and the Genotype MTBDRsl version 2.0 assay was significant (P < 0.01) of moxifloxacin (MFX) concentration. Sensitivity and specificity value for kanamycin (KAN) resistance was 76% and 89%; 47% and 94% for capreomycin (CAP); and 60% and 76% for low-level KAN, respectively. Conclusion: Our results indicate that MFX (0.25and 1 μg/mL), KAN (2.5 μg/mL), and CAP (2.5 μg/mL) significantly (P < 0.01) and support the World Health Organization guidance to test FQ and AMG by genotypic test.
first_indexed 2024-03-11T15:44:30Z
format Article
id doaj.art-cef080d590d74addb89b79a63698339d
institution Directory Open Access Journal
issn 2212-5531
2212-554X
language English
last_indexed 2024-03-11T15:44:30Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Mycobacteriology
spelling doaj.art-cef080d590d74addb89b79a63698339d2023-10-26T07:27:42ZengWolters Kluwer Medknow PublicationsInternational Journal of Mycobacteriology2212-55312212-554X2023-01-0112329930410.4103/ijmy.ijmy_120_23Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosidesRamalingam RadhakrishnanS PrabuseenivasanS HannahV VaishanaveeV SenthildeviT KannadhasanR SuchithraPriya RajendranPonnuraja ChinnaiyanLavanya JayabalAsha FrederickSivakumar ShanmugamBackground: Information on genotypic with comparison of phenotypic drug sensitivity test of anti-tuberculosis (TB) has been reported in several studies, which have variable results. The present study aimed to assess the Genotype MTBDRsl version 2.0/Line probe assay (LPA) for the detection of fluoroquinolones (FQ) and aminoglycosides (AMGs) resistance mutations among drug-resistant Mycobacterium TB (MTB) strains and also to compare the patterns of genotypic mutations of gyrA/B, rrs, and eis with mycobacteria growth indicator tube (MGIT 960). Methods: A total of 1416 samples were subjected to Genotype MTBDRsl version 2.0 assay. One hundred and twenty sputum smear positive MTB isolates and 37 sputum smear negative MTB isolates confirmed multiple drug resistance resistant to FQ and AMG by the Genotype MTBDRsl version 2.0 were subjected to phenotypic drug susceptibility testing (DST) were analyzed. Results: The association sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for the resistance detection between MGIT (DST) and the Genotype MTBDRsl version 2.0 assay was significant (P < 0.01) of moxifloxacin (MFX) concentration. Sensitivity and specificity value for kanamycin (KAN) resistance was 76% and 89%; 47% and 94% for capreomycin (CAP); and 60% and 76% for low-level KAN, respectively. Conclusion: Our results indicate that MFX (0.25and 1 μg/mL), KAN (2.5 μg/mL), and CAP (2.5 μg/mL) significantly (P < 0.01) and support the World Health Organization guidance to test FQ and AMG by genotypic test.http://www.ijmyco.org/article.asp?issn=2212-5531;year=2023;volume=12;issue=3;spage=299;epage=304;aulast=Radhakrishnanaminoglycosidesfluoroquinolonesline probe assay
spellingShingle Ramalingam Radhakrishnan
S Prabuseenivasan
S Hannah
V Vaishanavee
V Senthildevi
T Kannadhasan
R Suchithra
Priya Rajendran
Ponnuraja Chinnaiyan
Lavanya Jayabal
Asha Frederick
Sivakumar Shanmugam
Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides
International Journal of Mycobacteriology
aminoglycosides
fluoroquinolones
line probe assay
title Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides
title_full Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides
title_fullStr Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides
title_full_unstemmed Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides
title_short Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides
title_sort genotype mtbdrsl version 2 and phenotypic drug resistance detection of mycobacterium tuberculosis for fluoroquinolones and aminoglycosides
topic aminoglycosides
fluoroquinolones
line probe assay
url http://www.ijmyco.org/article.asp?issn=2212-5531;year=2023;volume=12;issue=3;spage=299;epage=304;aulast=Radhakrishnan
work_keys_str_mv AT ramalingamradhakrishnan genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT sprabuseenivasan genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT shannah genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT vvaishanavee genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT vsenthildevi genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT tkannadhasan genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT rsuchithra genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT priyarajendran genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT ponnurajachinnaiyan genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT lavanyajayabal genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT ashafrederick genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides
AT sivakumarshanmugam genotypemtbdrslversion2andphenotypicdrugresistancedetectionofmycobacteriumtuberculosisforfluoroquinolonesandaminoglycosides